Depot medroxyprogesterone acetate and the risk for developing an intracranial meningioma

John P. Micha, Randy D. Bohart, Andrew S. Gorman, Bram H. Goldstein

Open source

DOI
10.1002/ijgo.71361
Published
2026-09-21
Container
International Journal of Gynecology & Obstetrics
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/ijgo.71361,
  title = {Depot medroxyprogesterone acetate and the risk for developing an intracranial meningioma},
  author = {John P. Micha and Randy D. Bohart and Andrew S. Gorman and Bram H. Goldstein},
  year = {2026},
  journal = {International Journal of Gynecology \& Obstetrics},
  doi = {10.1002/ijgo.71361},
  url = {https://doi.org/10.1002/ijgo.71361}
}

RIS

TY  - JOUR
TI  - Depot medroxyprogesterone acetate and the risk for developing an intracranial meningioma
AU  - John P. Micha
AU  - Randy D. Bohart
AU  - Andrew S. Gorman
AU  - Bram H. Goldstein
PY  - 2026
JO  - International Journal of Gynecology & Obstetrics
DO  - 10.1002/ijgo.71361
UR  - https://doi.org/10.1002/ijgo.71361
ER  - 

APA

Micha, J. P., Bohart, R. D., Gorman, A. S., & Goldstein, B. H. (2026). Depot medroxyprogesterone acetate and the risk for developing an intracranial meningioma. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.71361

Source records